| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $709.9M | +12.9% |
| Cost of Revenue | $952.0M | -24.1% |
| Gross Profit | -$242.0M | +61.3% |
| R&D Expense | $58.0M | -24.9% |
| SG&A Expense | $379.6M | +0.9% |
| Operating Income | -$1.47B | +27.4% |
| Interest Expense | $65.1M | +39.7% |
| Pre-tax Income | -$1.69B | +19.7% |
| Income Tax | $356K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $368.5M | +79.2% |
| Accounts Receivable | $134.8M | -14.3% |
| Inventory | $521.0M | -23.7% |
| Current Assets | $1.41B | -4.5% |
| Total Assets | $2.59B | -28.0% |
| Current Liabilities | $610.6M | -18.4% |
| Total Liabilities | $1.59B | -11.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$535.8M | +26.5% |
| Capital Expenditures | $111.2M | -61.3% |
| Investing Cash Flow | -$139.0M | +65.5% |
| Financing Cash Flow | $630.0M | -35.9% |
| Free Cash Flow | -$647.0M | +36.3% |
| +113.3% |
| Net Income | -$1.63B | +22.5% |
| EPS (Basic) | -$1.42 | +47.0% |
| EPS (Diluted) | -$1.42 | +47.0% |
| Stockholders' Equity |
| $978.1M |
| -43.6% |